Tuberculosis Vaccines

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

  • Scientific challenges facing the TB vaccine field
  • Next Generation TB Vaccines and Vaccine Concepts
  • TB vaccine development

Related Conference of Tuberculosis Vaccines

June 09-09, 2021

Global Summit on Vaccines and Immunology

Chicago, USA
June 09-10, 2021

Global Summit on HIV-AIDS and STDs

Chicago, USA
June 09-10, 2021

Global Summit on Vaccines & Emerging Diseases

Chicago, USA
June 14-15, 2021

Global Summit on Hepatitis Vaccine

Rome, Italy
July 29-30, 2021

33rd Annual Congress on Immunology and Vaccinations

Vancouver, Canada

Tuberculosis Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in